| NCT ID | Title | Status | Phases | Start Date | Completion Date | Primary Completion Date |
|---|---|---|---|---|---|---|
| NCT06146101 | RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA | ACTIVE_NOT_RECRUITING | PHASE2, PHASE3 | 2024-05-02 | 2026-12 | 2026-12 |
| NCT05942911 | Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis | SUSPENDED | PHASE2 | 2023-11-22 | 2025-10-28 | 2024-10-28 |
| NCT05857384 | Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs | COMPLETED | PHASE1 | 2023-09-08 | 2024-07-31 | 2024-07-31 |